publication venue for
- Anti-GITR antibodies--potential clinical applications for tumor immunotherapy. 2010
- The role of KRAS mutations in resistance to EGFR inhibition in the treatment of cancer. 2009
- The adipocyte IKK/NFkappaB pathway: a therapeutic target for insulin resistance. 2009
- Herpesviruses and autoimmunity. 2008
- Progesterone receptor antagonists. 2006
- Drug evaluation: AMG-531 for the treatment of thrombocytopenias. 2006
- Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today's agents. 2006
- Aromatase inhibitors for hormonal therapy of early-stage breast cancer. 2004
- Vaccinating against GD3 ganglioside using BEC2 anti-idiotypic monoclonal antibody. 2003
- ONYX-015. Onyx Pharmaceuticals. 2001
- Recent success with the tyrosine kinase inhibitor STI-571--lessons for targeted therapy of cancer. 2001
- Intraductal therapy for the prevention of breast cancer. 2010
- Advances in oncolytic viral therapy. 2006
- Targeting mTOR for cancer treatment. 2006